0 431

Cited 118 times in

Perforation in colorectal stenting: a meta-analysis and a search for risk factors.

DC Field Value Language
dc.contributor.author천재희-
dc.date.accessioned2015-12-28T10:57:07Z-
dc.date.available2015-12-28T10:57:07Z-
dc.date.issued2014-
dc.identifier.issn0016-5107-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/138376-
dc.description.abstractBACKGROUND: Recent studies suggest that there is a substantial risk of perforation after colorectal stent placement. OBJECTIVE: To identify risk factors for perforation from colonic stenting. DESIGN: A meta-analysis of 86 studies published between 2005 and 2011. SETTING: Multicenter review. PATIENTS: All patients who underwent colorectal stent placement. INTERVENTION: Colorectal stent placement. MAIN OUTCOME MEASUREMENTS: The occurrence of perforation with subgroup analyses for stent design, stricture etiology, stricture dilation, and concomitant chemotherapy, including the use of bevacizumab. RESULTS: A total of 4086 patients underwent colorectal stent placement; perforation occurred in 207. Meta-analysis revealed an overall perforation rate of 7.4%. Of the 9 most frequently used stent types, the WallFlex, the Comvi, and the Niti-S D-type had a higher perforation rate (>10%). A lower perforation rate (<5%) was found for the Hanarostent and the Niti-S covered stent. Stenting benign strictures was associated with a significantly increased perforation rate of 18.4% compared with 7.5% for malignant strictures. Dilation did not increase the risk of perforation: 8.5% versus 8.5% without dilation. The subgroup of post-stent placement dilation had a significantly increased perforation risk of 20.4%. With a perforation rate of 12.5%, bevacizumab-based therapy was identified as a risk factor for perforation, whereas the risk for chemotherapy without bevacizumab was 7.0% and not increased compared with the group without concomitant therapies during stent therapy (9.0%). LIMITATIONS: Heterogeneity; a considerable proportion of data is unavailable for subgroup analysis. CONCLUSIONS: The perforation rate of colonic stenting is 7.4%. Stent design, benign etiology, and bevacizumab were identified as risk factors for perforation. Intraprocedural stricture dilation and concomitant chemotherapy were not associated with an increased risk of perforation.-
dc.description.statementOfResponsibilityopen-
dc.format.extent970~982-
dc.relation.isPartOfGASTROINTESTINAL ENDOSCOPY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHColon/injuries*-
dc.subject.MESHColonic Diseases/surgery*-
dc.subject.MESHGlobal Health-
dc.subject.MESHHumans-
dc.subject.MESHIncidence-
dc.subject.MESHIntestinal Obstruction/surgery*-
dc.subject.MESHIntestinal Perforation*/diagnosis-
dc.subject.MESHIntestinal Perforation*/epidemiology-
dc.subject.MESHIntestinal Perforation*/etiology-
dc.subject.MESHIntraoperative Complications*-
dc.subject.MESHRisk Assessment/methods*-
dc.subject.MESHRisk Factors-
dc.subject.MESHStents/adverse effects*-
dc.titlePerforation in colorectal stenting: a meta-analysis and a search for risk factors.-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorEmo E. van Halsema-
dc.contributor.googleauthorJeanin E. van Hooft-
dc.contributor.googleauthorAaron J. Small-
dc.contributor.googleauthorTodd H. Baron-
dc.contributor.googleauthorJesús García-Cano-
dc.contributor.googleauthorJae Hee Cheon-
dc.contributor.googleauthorMoon Sung Lee-
dc.contributor.googleauthorSe Hwan Kwon-
dc.contributor.googleauthorStéphanie Mucci-Hennekinne-
dc.contributor.googleauthorPaul Fockens-
dc.contributor.googleauthorMarcel G.W. Dijkgraaf-
dc.contributor.googleauthorAlessandro Repici-
dc.identifier.doi10.1016/j.gie.2013.11.038-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA04030-
dc.relation.journalcodeJ00920-
dc.identifier.eissn1097-6779-
dc.identifier.pmid24650852-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0016510713026345-
dc.contributor.alternativeNameCheon, Jae Hee-
dc.contributor.affiliatedAuthorCheon, Jae Hee-
dc.rights.accessRightsfree-
dc.citation.volume79-
dc.citation.number6-
dc.citation.startPage970-
dc.citation.endPage982-
dc.identifier.bibliographicCitationGASTROINTESTINAL ENDOSCOPY, Vol.79(6) : 970-982, 2014-
dc.identifier.rimsid49135-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.